Yandex Terminates Agreement to Acquire Its Moscow

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Yandex Terminates Agreement to Acquire Its Moscow Headquarters

MOSCOW and AMSTERDAM, the Netherlands, Sept. 08, 2016 (GLOBE NEWSWIRE) -- Yandex N.V. (NASDAQ: YNDX ) (“Yandex”), one of the largest European internet companies and the leading search provider in Russia, today announced that it has terminated the Framework Agreement entered into on February 19, 2016 with Krasnaya Roza 1875 Limited, a Cypriot company (“KR1875”) (the “Framework Agreement”), pursuant to which Yandex was to become the sole owner of the company which holds title to the office complex in central Moscow (the “Red Rose”) that houses the Yandex group’s Russian headquarters. 

Yandex has opted to terminate the Framework Agreement because of changing market conditions. The Framework Agreement allows for Yandex to terminate the Framework Agreement at any time prior to closing. In the event of the termination of the agreement, the Framework Agreement stipulates that Yandex will reimburse KR1875 for certain fees and expense incurred in connection with the transaction, up to a maximum of 45 million rubles (approximately $700,000). Yandex believes that after the reimbursement of these costs to KR1875, it remains in the company’s and stockholders’ interest to terminate the Framework Agreement. Yandex plans to remain at the Red Rose through the end of the lease term but may consider other options for when the lease term expires.

Contact:

Investor Relations Katya Zhukova Phone: +7 495 974-3538 E-mail: askIR@yandex-team.com  

Media Relations Ochir Mandzhikov, Asya Melkumova Phone: +7 495 739-7000 E-mail: pr@yandex-team.com  

ABOUT YANDEX

Yandex (NASDAQ: YNDX ) is one of the largest European internet companies, providing a wide variety of search and other online services. Yandex’s mission is to help users solve their everyday problems by building people-centric products and services. Based on innovative technologies, the company provides the most relevant, locally tailored experience on all digital platforms and devices. Yandex operates Russia’s most popular search engine and also serves Ukraine, Belarus, Kazakhstan and Turkey. More information on Yandex can be found at https://yandex.com/company . 

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements that involve risks and uncertainties. These include statements regarding the anticipated closing of the transaction described above and the impact of such transaction on the Company’s financial results. Actual results may differ materially from the results predicted or implied by such statements. The potential risks and uncertainties that could cause actual results to differ from the results predicted or implied by such statements include, among others, the satisfaction of the conditions to closing and macroeconomic and geopolitical developments affecting the Russian economy, as well as those risks and uncertainties included under the captions “Risk Factors” and “Operating and Financial Review and Prospects” in our Annual Report on Form 20-F for the year ended December 31, 2015, which is on file with the Securities and Exchange Commission and is available on our investor relations website at http://ir.yandex.com/sec.cfm and on the SEC website at www.sec.gov. All information in this release and in the attachments is as of September 7, 2016, and Yandex undertakes no duty to update this information unless required by law.

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmVira's Bladder Cancer Trials: Promising Data Revealed

Updated Category News Views 3

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

Continue Reading
Resilience: From Trauma to Shielding Powerhouses

Updated Category News Views 6

A Childhood Steeped in Shadows If you think it's all Wall Street pulse for me, think again. Sometimes you stumble upon stories that hit the gut with more force than any market crash. Enter David Seymour's tale, wrapped up in his newly released autobiography from Palmetto Publishing, bearing the intriguingly gritty title: From paperboy to Secret Service Special Agent. This...

Continue Reading
ThreatLocker Launches Global AI Awareness Campaign

Updated Category News Views 4

Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...

Continue Reading
Camel Group Expands Battery Portfolio at Canton Fair

Updated Category News Views 3

A Grand Display at the Canton Fair Well, here's one you don't see every day: Camel Group putting on quite the show at the 140th China Import and Export Fair, better known to us as the Canton Fair. Kicked off on October 15, 2026, in Guangzhou, this grand event paraded 'Advanced Manufacturing' as its theme, and Camel's booth was packed to the brim with what might just be...

Continue Reading
ZPMC's Wind Power and Port Projects Earn Top Honors

Updated Category News Views 1

Wind Farms and Ports: A Winning Formula National applause rings out for Shanghai Zhenhua Heavy Industries Co., Ltd. (ZPMC) as they snagged top honors in the recent National Quality Engineering Awards. It's about time folks recognized the heavy lifting these projects do in reshaping our energy and port infrastructure. Two of their standout projects walked away with...

Continue Reading
Encompass Health Expands With Texas Rehab Hospital

Updated Category News Views 6

A New Chapter in San Antonio's Healthcare Landscape Breaking ground in Texas, Encompass Health has unveiled its latest addition: a 50-bed hospital in San Antonio's Westover Hills. With sheer determination, the largest owner of inpatient rehabilitation hospitals in the U.S. has made its mark, and this isn't just any facility—at over 54,000 square feet, it's a hub for...

Continue Reading
Union Alarmtronic Joins Forces with Pye-Barker in Key Sale

Updated Category News Views 3

A Key Merger in Security Sector Here's a deal that's got the market talking: Union Alarmtronic, a stalwart in the security systems arena, has tied the knot with Pye-Barker Fire & Safety, one of the biggest names in fire protection and life safety. This move isn't just another line in the 'mergers & acquisitions' logbook; it's a strategic shift that underscores the growing...

Continue Reading
Duni Group Faces Ups and Downs in Q3 2026

Updated Category News Views 1

Navigating Choppy Waters: Duni's Third Quarter 2026 Alright, folks, let's dive into the latest from Duni Group—a company feeling the pinch but pushing through with some resilience. The third quarter 2026 report has just landed, and while some numbers are headed up, plenty are a bit of a gut punch. This isn't a crisis, but it's no smooth sailing either. Let's cut through...

Continue Reading
Groundbreaking Sale: Lani Automotive Acquires Iowa Dealership

Updated Category News Views 6

A shift in the automotive retail world takes place with Lani Automotive Group's latest move. They've just picked up their first franchised dealership, Mount Pleasant Chevrolet GMC Chrysler Dodge Jeep Ram in Iowa. It's a mouthful, sure, but it packs a punch in terms of potential growth. Why This Sale Stands Out The deal was brokered by Performance Brokerage Services, which...

Continue Reading
Marengo: Bold Moves in TMB-H Tumor Treatment

Updated Category News Views 0

A New Hope for Tough Tumors? Marengo Therapeutics is stirring up the oncology world with some intriguing Phase 2 results from their STARt-001 clinical trial, revealing invikafusp alfa's potential as a single-agent therapy. This hasn’t been a walk in the park, mind you; we're talking about dealing with TMB-H solid tumors that typically thumb their noses at immune...

Continue Reading
iv>